- Home
- GERN vs BUSE Comparison
GERN vs BUSE Comparison
Compare GERN & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- BUSE
- Stock Information
- Founded
- GERN 1990
- BUSE 1868
- Country
- GERN United States
- BUSE United States
- Employees
- GERN N/A
- BUSE N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- BUSE Major Banks
- Sector
- GERN Health Care
- BUSE Finance
- Exchange
- GERN Nasdaq
- BUSE Nasdaq
- Market Cap
- GERN 1.5B
- BUSE 1.4B
- IPO Year
- GERN 1996
- BUSE N/A
- Fundamental
- Price
- GERN $2.57
- BUSE $24.25
- Analyst Decision
- GERN Strong Buy
- BUSE Buy
- Analyst Count
- GERN 11
- BUSE 4
- Target Price
- GERN $6.82
- BUSE $28.75
- AVG Volume (30 Days)
- GERN 12.4M
- BUSE 355.4K
- Earning Date
- GERN 02-26-2025
- BUSE 01-28-2025
- Dividend Yield
- GERN N/A
- BUSE 4.12%
- EPS Growth
- GERN N/A
- BUSE N/A
- EPS
- GERN N/A
- BUSE 1.98
- Revenue
- GERN $29,480,000.00
- BUSE $453,703,000.00
- Revenue This Year
- GERN $31,918.56
- BUSE N/A
- Revenue Next Year
- GERN $289.41
- BUSE $12.48
- P/E Ratio
- GERN N/A
- BUSE $12.25
- Revenue Growth
- GERN 9199.68
- BUSE 3.25
- 52 Week Low
- GERN $1.64
- BUSE $21.59
- 52 Week High
- GERN $5.34
- BUSE $28.97
- Technical
- Relative Strength Index (RSI)
- GERN 31.98
- BUSE 48.86
- Support Level
- GERN $2.49
- BUSE $24.31
- Resistance Level
- GERN $2.84
- BUSE $25.31
- Average True Range (ATR)
- GERN 0.15
- BUSE 0.72
- MACD
- GERN -0.01
- BUSE 0.01
- Stochastic Oscillator
- GERN 13.33
- BUSE 39.19
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech, and Wealth Management. The banking segment generates a vast majority of its revenue.